
- <Centre d'Information et de documentation du CRA Rhône-Alpes
- CRA
- Informations pratiques
-
Adresse
Centre d'information et de documentation
Horaires
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexLundi au Vendredi
Contact
9h00-12h00 13h30-16h00Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Adresse
Détail de l'auteur
Auteur James B. ADAMS |
Documents disponibles écrits par cet auteur (4)



Autism severity and muscle strength: A correlation analysis / Janet K. KERN in Research in Autism Spectrum Disorders, 5-3 (July-September 2011)
![]()
[article]
Titre : Autism severity and muscle strength: A correlation analysis Type de document : Texte imprimé et/ou numérique Auteurs : Janet K. KERN, Auteur ; David A. GEIER, Auteur ; James B. ADAMS, Auteur ; Melissa R. TROUTMAN, Auteur ; Georgia DAVIS, Auteur ; Paul G. KING, Auteur ; John L. YOUNG, Auteur ; Mark R. GEIER, Auteur Année de publication : 2011 Article en page(s) : p.1011-1015 Langues : Anglais (eng) Mots-clés : Autism Autism severity Muscle strength Grip strength Index. décimale : PER Périodiques Résumé : The current study examined the relationship between muscle strength, as measured by hand grip strength, and autism severity, as measured by the Childhood Autism Rating Scale (CARS). Thirty-seven (37) children with a diagnosis of autism spectrum disorder (ASD) were evaluated using the CARS and then tested for hand muscle strength using a hand grip dynamometer. Statistical analysis was then conducted to examine the relationship between autism severity and hand muscle strength. The model generated in the present study showed that the CARS score is a significant predictor of Max Hand Muscle Score after adjustment for age, race, gender, year of birth, and a history of prior chelation therapy. Evidence suggests that hand grip strength in children with ASD is related to the severity of the disorder. Further research is needed to determine the extent and consistency of the muscle weakness and possible treatments. En ligne : http://dx.doi.org/10.1016/j.rasd.2010.11.002 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=118
in Research in Autism Spectrum Disorders > 5-3 (July-September 2011) . - p.1011-1015[article] Autism severity and muscle strength: A correlation analysis [Texte imprimé et/ou numérique] / Janet K. KERN, Auteur ; David A. GEIER, Auteur ; James B. ADAMS, Auteur ; Melissa R. TROUTMAN, Auteur ; Georgia DAVIS, Auteur ; Paul G. KING, Auteur ; John L. YOUNG, Auteur ; Mark R. GEIER, Auteur . - 2011 . - p.1011-1015.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 5-3 (July-September 2011) . - p.1011-1015
Mots-clés : Autism Autism severity Muscle strength Grip strength Index. décimale : PER Périodiques Résumé : The current study examined the relationship between muscle strength, as measured by hand grip strength, and autism severity, as measured by the Childhood Autism Rating Scale (CARS). Thirty-seven (37) children with a diagnosis of autism spectrum disorder (ASD) were evaluated using the CARS and then tested for hand muscle strength using a hand grip dynamometer. Statistical analysis was then conducted to examine the relationship between autism severity and hand muscle strength. The model generated in the present study showed that the CARS score is a significant predictor of Max Hand Muscle Score after adjustment for age, race, gender, year of birth, and a history of prior chelation therapy. Evidence suggests that hand grip strength in children with ASD is related to the severity of the disorder. Further research is needed to determine the extent and consistency of the muscle weakness and possible treatments. En ligne : http://dx.doi.org/10.1016/j.rasd.2010.11.002 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=118 Biochemical Effects of Ribose and NADH Therapy in Children with Autism / Stuart H. FREEDENFELD in Autism Insights, 3 ([01/01/2011])
![]()
[article]
Titre : Biochemical Effects of Ribose and NADH Therapy in Children with Autism Type de document : Application, site Internet Auteurs : Stuart H. FREEDENFELD, Auteur ; Kim HAMADA, Auteur ; Tapan AUDHYA, Auteur ; James B. ADAMS, Auteur Année de publication : 2011 Article en page(s) : 11 p. Langues : Anglais (eng) Mots-clés : NADH ribose autism mitochondria glutathione methylation adenosine Index. décimale : PER Périodiques Résumé : Objectives: Several studies have previously indicated that children with autism often have abnormalities in methylation, glutathione redox, and mitochondrial function. A common feature of these abnormalities is that they are affected directly or indirectly by levels of ribose, reduced Nicotinamide Adenine Dinucleotide (NADH), reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH), and Adenosine-5’-triphosphate (ATP). The objective of this study was to investigate the possible biochemical effect of ribose therapy and NADH therapy on children with autism.
Design: In a pilot study, ribose was administered orally to eight children with autism for two weeks, and NADH was administered orally to another group of eight children with autism for two weeks. Children were ages 3–9 years with clinical symptoms of low energy and/or low muscle tone. Eighteen biomarkers related to methylation (including S-adenosylmethionine (SAM)), glutathione (including the reduced form, GSH, and the oxidized form GSSG), adenosine triphosphate (ATP), and folic acid and were measured at the beginning and end of the therapy.
Results: The NADH group had significant improvements in levels of ribose-5-phosphate, GSH, NADH, NADPH, and SAM. The Ribose group had significant improvements in ribose-5-phosphate, NADH, ATP, and folic acid. There was no significant change in GSSG in either group after two weeks.
Conclusions: This small study suggests that both NADH and Ribose therapy results in some improvements in biochemistry, and may be beneficial for treating children with those abnormalities. Larger studies are recommended.En ligne : http://dx.doi.org/10.4137/AUI.S6947 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=131
in Autism Insights > 3 [01/01/2011] . - 11 p.[article] Biochemical Effects of Ribose and NADH Therapy in Children with Autism [Application, site Internet] / Stuart H. FREEDENFELD, Auteur ; Kim HAMADA, Auteur ; Tapan AUDHYA, Auteur ; James B. ADAMS, Auteur . - 2011 . - 11 p.
Langues : Anglais (eng)
in Autism Insights > 3 [01/01/2011] . - 11 p.
Mots-clés : NADH ribose autism mitochondria glutathione methylation adenosine Index. décimale : PER Périodiques Résumé : Objectives: Several studies have previously indicated that children with autism often have abnormalities in methylation, glutathione redox, and mitochondrial function. A common feature of these abnormalities is that they are affected directly or indirectly by levels of ribose, reduced Nicotinamide Adenine Dinucleotide (NADH), reduced Nicotinamide Adenine Dinucleotide Phosphate (NADPH), and Adenosine-5’-triphosphate (ATP). The objective of this study was to investigate the possible biochemical effect of ribose therapy and NADH therapy on children with autism.
Design: In a pilot study, ribose was administered orally to eight children with autism for two weeks, and NADH was administered orally to another group of eight children with autism for two weeks. Children were ages 3–9 years with clinical symptoms of low energy and/or low muscle tone. Eighteen biomarkers related to methylation (including S-adenosylmethionine (SAM)), glutathione (including the reduced form, GSH, and the oxidized form GSSG), adenosine triphosphate (ATP), and folic acid and were measured at the beginning and end of the therapy.
Results: The NADH group had significant improvements in levels of ribose-5-phosphate, GSH, NADH, NADPH, and SAM. The Ribose group had significant improvements in ribose-5-phosphate, NADH, ATP, and folic acid. There was no significant change in GSSG in either group after two weeks.
Conclusions: This small study suggests that both NADH and Ribose therapy results in some improvements in biochemistry, and may be beneficial for treating children with those abnormalities. Larger studies are recommended.En ligne : http://dx.doi.org/10.4137/AUI.S6947 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=131 Investigating plasma amino acids for differentiating individuals with autism spectrum disorder and typically developing peers / Troy VARGASON in Research in Autism Spectrum Disorders, 50 (June 2018)
![]()
[article]
Titre : Investigating plasma amino acids for differentiating individuals with autism spectrum disorder and typically developing peers Type de document : Texte imprimé et/ou numérique Auteurs : Troy VARGASON, Auteur ; Uwe KRUGER, Auteur ; Deborah L. MCGUINNESS, Auteur ; James B. ADAMS, Auteur ; Elizabeth GEIS, Auteur ; Eva GEHN, Auteur ; Devon COLEMAN, Auteur ; Juergen HAHN, Auteur Année de publication : 2018 Article en page(s) : p.60-72 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Plasma amino acids Fisher discriminant analysis Classification Multivariate statistics Cross-validation Index. décimale : PER Périodiques Résumé : Background Plasma amino acid measurements have been extensively investigated in individuals with autism spectrum disorder (ASD). Results thus far have been inconclusive as studies generally disagree on which amino acids are different in individuals with ASD versus their typically developing (TD) peers, due in part to methodological limitations of several studies. Method This paper investigates plasma amino acids in children and adults with ASD using data from Arizona State University’s Comprehensive Nutritional and Dietary Intervention Study. Measurements from 64 individuals with ASD and 49 TD controls were analyzed using univariate and multivariate statistical techniques. Results Univariate analysis indicated increased median levels of glutamate (+21%, p?=?0.014) and serine (+8%, p?=?0.043), and increased mean levels of hydroxyproline (+17%, p?=?0.018) for the ASD cohort, although these differences were insignificant after correcting for multiple comparisons. A multivariate approach was used to classify study participants into ASD/TD cohorts using Fisher discriminant analysis (FDA) and its nonlinear extension, kernel Fisher discriminant analysis (KFDA). Model fitting with FDA using all available measurements produced Type I and Type II errors of 27.0% and 27.8%, respectively. KFDA was most effective when using hydroxyproline, leucine, and threonine as inputs; however, leave-one-out cross-validation with this nonlinear model only resulted in 70.3% sensitivity and 77.6% specificity. Conclusions The finding of elevated glutamate in ASD is in agreement with several other studies. Overall, however, these results suggest that plasma amino acid measurements are of limited use for purposes of ASD classification, which may explain some of the inconsistencies in results presented in the literature. En ligne : https://doi.org/10.1016/j.rasd.2018.03.004 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=356
in Research in Autism Spectrum Disorders > 50 (June 2018) . - p.60-72[article] Investigating plasma amino acids for differentiating individuals with autism spectrum disorder and typically developing peers [Texte imprimé et/ou numérique] / Troy VARGASON, Auteur ; Uwe KRUGER, Auteur ; Deborah L. MCGUINNESS, Auteur ; James B. ADAMS, Auteur ; Elizabeth GEIS, Auteur ; Eva GEHN, Auteur ; Devon COLEMAN, Auteur ; Juergen HAHN, Auteur . - 2018 . - p.60-72.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 50 (June 2018) . - p.60-72
Mots-clés : Autism spectrum disorder Plasma amino acids Fisher discriminant analysis Classification Multivariate statistics Cross-validation Index. décimale : PER Périodiques Résumé : Background Plasma amino acid measurements have been extensively investigated in individuals with autism spectrum disorder (ASD). Results thus far have been inconclusive as studies generally disagree on which amino acids are different in individuals with ASD versus their typically developing (TD) peers, due in part to methodological limitations of several studies. Method This paper investigates plasma amino acids in children and adults with ASD using data from Arizona State University’s Comprehensive Nutritional and Dietary Intervention Study. Measurements from 64 individuals with ASD and 49 TD controls were analyzed using univariate and multivariate statistical techniques. Results Univariate analysis indicated increased median levels of glutamate (+21%, p?=?0.014) and serine (+8%, p?=?0.043), and increased mean levels of hydroxyproline (+17%, p?=?0.018) for the ASD cohort, although these differences were insignificant after correcting for multiple comparisons. A multivariate approach was used to classify study participants into ASD/TD cohorts using Fisher discriminant analysis (FDA) and its nonlinear extension, kernel Fisher discriminant analysis (KFDA). Model fitting with FDA using all available measurements produced Type I and Type II errors of 27.0% and 27.8%, respectively. KFDA was most effective when using hydroxyproline, leucine, and threonine as inputs; however, leave-one-out cross-validation with this nonlinear model only resulted in 70.3% sensitivity and 77.6% specificity. Conclusions The finding of elevated glutamate in ASD is in agreement with several other studies. Overall, however, these results suggest that plasma amino acid measurements are of limited use for purposes of ASD classification, which may explain some of the inconsistencies in results presented in the literature. En ligne : https://doi.org/10.1016/j.rasd.2018.03.004 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=356 Urinary essential elements of young children with autism spectrum disorder and their mothers / Fatir QURESHI in Research in Autism Spectrum Disorders, 72 (April 2020)
![]()
[article]
Titre : Urinary essential elements of young children with autism spectrum disorder and their mothers Type de document : Texte imprimé et/ou numérique Auteurs : Fatir QURESHI, Auteur ; James B. ADAMS, Auteur ; Devon COLEMAN, Auteur ; David QUIG, Auteur ; Juergen HAHN, Auteur Article en page(s) : p.101518 Langues : Anglais (eng) Mots-clés : ASD Metabolism Essential elements Urine analysis Index. décimale : PER Périodiques Résumé : Background Even though the cause of autism spectrum disorders (ASD) remains unknown, the current understanding points towards complex interactions between environmental and genetic factors. One important environmental factor to consider is intake of toxic and essential elements, and their role in metabolism. Essential elements have received considerably less attention in the literature than the presence of toxins in urine. Method The purpose of this investigation is to comprehensively assess the association between urinary element compositions of 28 mothers who had young children with ASD and 29 mothers who had young typically developing (TD) children, and in a subset of their children (21 with ASD and 26 TD). Results The results show that there are significant differences between the ASD and TD children cohorts’ concentrations for four specific elements (sulfur, phosphorous, molybdenum, and tin). Utilizing multivariate statistical techniques (Fisher’s discriminant analysis and support vector machines), it was possible to distinguish the ASD from the TD children groups with an 81 % accuracy after cross-validation utilizing the four significantly different elements. However, among the mother cohorts assessed, there were no significant differences between those that had children with ASD and those with TD children. There was a significant correlation of levels of phosphorus and sulfur in the children with ASD (r?=?0.63, p?=?3.0E-3) and in the TD children (r?=?0.47, p?=?0.02). Conclusions Notable differences were observed between the elemental concentration in urine of children with ASD and their TD peers. Analyzing cellular pathways related to these elements are promising areas of future research. En ligne : https://doi.org/10.1016/j.rasd.2020.101518 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=420
in Research in Autism Spectrum Disorders > 72 (April 2020) . - p.101518[article] Urinary essential elements of young children with autism spectrum disorder and their mothers [Texte imprimé et/ou numérique] / Fatir QURESHI, Auteur ; James B. ADAMS, Auteur ; Devon COLEMAN, Auteur ; David QUIG, Auteur ; Juergen HAHN, Auteur . - p.101518.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 72 (April 2020) . - p.101518
Mots-clés : ASD Metabolism Essential elements Urine analysis Index. décimale : PER Périodiques Résumé : Background Even though the cause of autism spectrum disorders (ASD) remains unknown, the current understanding points towards complex interactions between environmental and genetic factors. One important environmental factor to consider is intake of toxic and essential elements, and their role in metabolism. Essential elements have received considerably less attention in the literature than the presence of toxins in urine. Method The purpose of this investigation is to comprehensively assess the association between urinary element compositions of 28 mothers who had young children with ASD and 29 mothers who had young typically developing (TD) children, and in a subset of their children (21 with ASD and 26 TD). Results The results show that there are significant differences between the ASD and TD children cohorts’ concentrations for four specific elements (sulfur, phosphorous, molybdenum, and tin). Utilizing multivariate statistical techniques (Fisher’s discriminant analysis and support vector machines), it was possible to distinguish the ASD from the TD children groups with an 81 % accuracy after cross-validation utilizing the four significantly different elements. However, among the mother cohorts assessed, there were no significant differences between those that had children with ASD and those with TD children. There was a significant correlation of levels of phosphorus and sulfur in the children with ASD (r?=?0.63, p?=?3.0E-3) and in the TD children (r?=?0.47, p?=?0.02). Conclusions Notable differences were observed between the elemental concentration in urine of children with ASD and their TD peers. Analyzing cellular pathways related to these elements are promising areas of future research. En ligne : https://doi.org/10.1016/j.rasd.2020.101518 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=420